- Medical School: McGill University Faculty of Medicine, Montreal, Quebec, Canada
- Psychiatry Residency: Francis Scott Key Hospital, the Johns Hopkins Hospital, Baltimore, MD and the Maudsley Hospital, London, UK
Dr. Regenold's areas of interest include:
- brain energy metabolism in neuropsychiatric disorders, including bipolar disorder, schizophrenia, major depression and multiple sclerosis;
- white matter disease in neuropsychiatric disorders;
- the therapeutic mechanisms of action of ECT and lithium; and
- biological markers of neuropsychiatric disorders, including bipolar disorder and Alzheimer's disease.
Dr. Regenold is certified in psychiatry and has added qualifications in geriatric psychiatry from the American Board of Psychiatry and Neurology. His clinical work mostly involves older adults. Although he sees patients with a variety of psychiatric problems, he is particularly interested in patients whose psychiatric problems are associated with medical or neurological disorders. He also consults on patients of any age who are considering electroconvulsive therapy (ECT) and performs ECT at the University of Maryland Medical Center.
Selected Recent Publications
Regenold WT, Phatak P, Makley MJ, Stone RD, Kling MA: Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression. J Neurol Sci 275(1-2): 106-12, 2008.
Regenold WT, Hisley KC, Phatak P, Marano CM, Obuchowski A,Lefkowitz DM, Sassan A, Ohri S, Phillips TL, Dosanjh N, Conley RR, and Gullapalli R: Relationship of Cerebrospinal Fluid Glucose Metabolites to MRI Deep White Matter Hyperintensities and Treatment Resistance in Bipolar Disorder Patients. Bipolar Disorders, 10, 753-64, 2008.
Regenold WT, Phatak P, Marano CM, Sassan A, Conley RR, Kling MA. Elevated Cerebrospinal Fluid Lactate Concentrations in Patients with Bipolar Disorder and Schizophrenia: Implications for the Mitochondrial Dysfunction Hypothesis. Biol Psychiatry .65(6):489-94, 2009.
Ogunmefun A, Hasnain M, Alam A, Osuala T, Regenold WT: Effect of donepezil on tardive dyskinesia. J Clin Psychopharmacol 29 (1):102-4, 2009.
Zhang JM, Tonelli L, Regenold WT, McCarthy MM: Effects of neonatal flutamide treatment on hippocampal neurogenesis and synaptogenesis correlate with depression-like behaviors in preadolescent male rats. Neuroscience, 169 (1): 544-54, 2010.
Regenold WT, Pratt M, Nekkalapu S, Shapiro PS, Kristian T, Fiskum G: Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: Implications for brain energy metabolism and neurotrophic signaling. J Psychiatr Res, 46 (1): 95-104, 2012.
Lachner C, Steinle N, Regenold WT: The Neuropsychiatry of Vitamin B12 Deficiency in the Elderly. J Neuropsychiatry Clin Neurosci, 24 (1): 5-15, 2012.
Regenold WT: Lithium and the Expanding Brain. Biol Psychiatry, 72 (7) e17, 2012.
Lachner C, Martin C, John D, Nekkalapu S, Sasan A, Steinle N, Regenold WT: Older adult psychiatric inpatients with non-cognitive disorders should be screened for vitamin B12 deficiency. J Nutrition, Health and Aging, September 2013.
Faculty members: Update your contact information and create a profile.